Clinical Trial Site

Encinitas, California 92024

0 studies enrolling now · 2 studies all time

What they study most

High Cardiovascular Risk, Hypertension

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed